Could a 2-Day infusion save transplanted kidneys?

NCT ID NCT04005469

First seen Apr 26, 2026 · Last updated May 13, 2026 · Updated 2 times

Summary

This study tests if a drug called treprostinil can help protect a new kidney from injury during transplant surgery. About 20 adults receiving a deceased donor kidney will get the drug through an IV for two days. The goal is to see if it improves kidney function and reduces the need for dialysis after transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIA-REPERFUSION INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rhode Island Hospital

    RECRUITING

    Providence, Rhode Island, 02903, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.